Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iovance Biotherapeutics IncfiledCriticalIovance Biotherapeutics Inc
Publication of AR115203A1publicationCriticalpatent/AR115203A1/en
La presente proporciona procesos mejorados y/o abreviados y métodos para reprogramar los TIL a fin de preparar poblaciones terapéuticas del TIL con mayor eficacia terapéutica. Estos TIL reprogramados se usan en regímenes de tratamiento terapéuticos.The present provides improved and / or abbreviated processes and methods for reprogramming TILs to prepare therapeutic populations of TIL with greater therapeutic efficacy. These reprogrammed TILs are used in therapeutic treatment regimens.
ARP190100037A2018-01-082019-01-08
PROCESSES FOR GENERATING ENRICHED TIL PRODUCTS FOR T-CELL-SPECIFIC TUMOR ANTIGENS
AR115203A1
(en)